• 37% of Pulmonary Fibrosis Patients Treated with Ofev Maintained Lung Function, Presentation Showed
  • Only Half of IPF Patients Talk to Doctors About Treatments
  • Latest IPF Studies Also Support Esbriet for More Severe Lung Function Impairment
  • PBI-4050 Slows Pulmonary Fibrosis Patients’ Lung-function Decline, Phase 2 Trial Suggests
  • Bellerophon Presents Positive Trial Results for INOpulse in IPF-associated PH
  • Turning to Self-Compassion in Difficult Times
  • Galecto’s Inhaled TD139 Effective, Safe in Treating IPF Patients, Scottish Study Finds
  • Resokine Protein Reduced Lung Disease in Mice, aTyr Will Report at Conference
  • Genoa Secures $62 Million to Fund Phase 2 Trial of Inhaled Aerodyne for Idiopathic Pulmonary Fibrosis
  • Laboratory Mini-lung That Mimics Features of Real Lung May Speed Research and Treatments
  • Putting Financial Affairs in Order
  • I’m Not Just Being Stubborn: Rest Is Hard for Me